Rigel Pharmaceuticals
RIGL | NASDAQ
$43.73
-$0.73 (-1.64%)
At close: Nov 16, 2026, 4:00 PM ET
$43.73
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-1.64%
(1D)No price chart data available for 1D timeframe.
Rating
72
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #43/1021 (Top 4%)
Key Statistics
Market Data
Market Cap $823.43M
1D Range
43.36 45.70
52W Range
25.44 51.45
Valuation (TTM)
PE 2.82
PB 1.85
EV/EBITDA 8.78
Valuation (NTM)
Forward PE 13.60
Forward PEG -0.05
Price Target $67.00
Cash Flow
FCF Yield 10.9%
SBC Adj. FCF Yield 8.8%
SBC Impact -19.9%
Margins
Gross Margin 89.6%
Operating Margin 26.3%
FCF Margin 31.2%
Growth (CAGR)
Revenue 3Y | 5Y 29.6% |
14.4%
Dil EPS 3Y | 5Y 104.8% |
153.7%
FCF 3Y | 5Y 70.9% |
61.3%
Returns
ROA 58.6%
ROE 73.9%
ROIC 16.7%
Financial Health
Net Cash
$92.07M
Current Ratio 2.39
Interest Coverage 18.17
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers ...
Sector Healthcare
Industry Biotechnology
Employees 173
IPO Date Nov 29, 2000
Website www.rigel.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
$0.65
Miss -25.29%
YoY:
-55.48% REV
$80.89M
Beat +1.12%
YoY:
+16.45%Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
4
Consensus
Hold
Price Target
$67.00
Upside
+53.21%
Buy (2)
Hold (2)
Sell (0)
Add to Watchlist
Select watchlists to add or remove RIGL